• FDA: Limbrel linked to 'potentially life-threatening' problems

    One year ago - By Healio

    The FDA is investigating the drug Limbrel, a capsule-based product currently marketed as a medical food to manage the metabolic processes associated with osteoarthritis, for what the administration calls “serious adverse events.”
    Limbrel has been linked to a total of 194 of adverse events, including two “serious and potentially life-threatening” medical conditions - drug-induced liver injury and hypersensitivity pneumonitis - according to an FDA statement. Of the nearly 200 adverse events, 57 cases included sufficient
    Read more ...